Are there cancer cells in the thyroid? Have metastases detached themselves from a tumor and moved elsewhere in the body?
Diagnostic questions such as these can be answered by nuclear physicians using low-level, short-lived radioactive substances. These so-called radiopharmaceuticals spread throughout the organism in a unique fashion and accumulate in large numbers in cancer cells, for example. Their radioactive signal can be measured, thereby revealing the location of tumor cells.
Now in Europe for the first time the basic scientific principles for all permitted radiopharmaceuticals will be systematically presented and assessed – as part of the PEDDOSE.NET project. The European Commission is providing EUR 500,000 in funding.
Goals of the project
One of the goals is to describe current knowledge relating to any effects of low-level radioactive pharmaceuticals on health. The focus is on substances administered to children and young people for diagnostic purposes. Within the project, the scientists will collate and assess data on anticipated exposure to radiation and any associated risks. They then aim to recommend how these data should be collated in the development of new radiopharmaceuticals.
A further goal for PEDDOSE.NET is to devise recommendations and guidelines in order to drive scientific and technological innovations. For example, the scientists believe that it will be possible in future to administer radiopharmaceuticals in even smaller doses, thereby further reducing the hypothetical risk to patients.
Another of the project’s goals is to identify any areas in which further clinical studies may be required. On every issue the scientists will collaborate with the authorities responsible for approving new substances.
Results expected in fall 2011
It is expected that the project will be completed in fall 2011. Its results should further improve radiation protection for patients and make the use of nuclear-medical examinations even more targeted than it is now.
Partners involved in the project
Five partner institutes from four European countries are involved in PEDDOSE.NET; the scientific coordinator is Professor Michael Laßmann, chief physicist at the Department of Nuclear Medicine of the University of Würzburg.
The project is being coordinated by the European Institute for Biomedical Imaging Research (EIBIR) in Vienna. It has the support of the European Association of Nuclear Medicine (EANM). The project consortium is made up of members of the EANM Dosimetry Committee and experts from the German Federal Office for Radiation Protection.
Homepage of the PEDDOSE.NET project: http://www.peddose.net
Prof. Dr. Michael Laßmann, Department of Nuclear Medicine, University of Würzburg, T +49 (0)931 201-35500, firstname.lastname@example.org
Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
Foods of the future
15.08.2018 | Georg-August-Universität Göttingen
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
16.08.2018 | Life Sciences
16.08.2018 | Earth Sciences
16.08.2018 | Life Sciences